CellOxess Competitors and Similar CompaniesClear all

CellOxess's competitors and similar companies include Inflazome, SiteOne Therapeutics and Quanterix.
CellOxess
CellOxess
CellOxess is a company that provides healthcare and biotechnology services.
Inflazome
Inflazome
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
SiteOne Therapeutics
SiteOne Therapeutics
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
Quanterix
Quanterix
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.
Founding Date
Founding Date
1990
Founding Date
2016
Founding Date
2014
Founding Date
2007
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
Ewing Township, US HQ
Locations
Dublin 2, IE HQ
Brisbane City, AU
Cambridge, GB
Locations
San Francisco, US HQ
Bozeman, US
Locations
Billerica, US HQ
Baltimore, US
Philadelphia, US
San Diego, US
San Francisco, US
Seattle, US
Employees
Employees
4
Employees
156% decrease
Employees
2216% increase
Employees
24840% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
75 m
Valuation ($)
506.2 m

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 17m
Total funding raised
$ 17.8m
Total funding raised
$ 96.5m
For sources of this data, please see the company profile

View Company Profiles

Inflazome
HQ
Dublin 2, IE

Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.

View company
SiteOne Therapeutics
HQ
San Francisco, US
Employees
22↑ 16% increase

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.

View company
Quanterix
HQ
Billerica, US
Employees
248↑ 40% increase

Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.

View company